Grupos
Publicaciones
-
Alberti-Valls, M; Olave, S; Olomí, A; Macià, A; Eritja, N
Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment
Cancers 16 -. .
-
Albertí-Valls M; Megino-Luque C; Macià A; Gatius S; Matias-Guiu X; Eritja N
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.
Cancers 16 -. .
-
Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.
Cancers 14 -. .
-
Megino-Luque, C; Sisó, P; Mota-Martorell, N; Navaridas, R; de la Rosa I; Urdanibia, I; Alberti-Valls, M; Santacana, M; Pinyol, M; Bonifaci, N; Macià, A; Llobet-Navas, D; Gatius, S; Matias-Guiu, X; Eritja, N
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
MOLECULAR ONCOLOGY 16 2235-2259. .
Proyectos
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- LYOTEK
